Purification of Active Matrix Metalloproteinase Catalytic Domains and Its Use for Screening of Specific Stromelysin-3 Inhibitors

Author： Kannan R.   Ruff M.   Kochins J.G.   Manly S.P.   Stoll I.   El Fahime M.   Noël A.   Foidart J-M.   Rio M-C.   Dive V.   Basset P.  

Publisher： Academic Press

ISSN： 1046-5928

Source： Protein Expression and Purification, Vol.16, Iss.1, 1999-06, pp. : 76-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

3D QSAR pharmacophore-based virtual screening and molecular docking studies to identify novel matrix metalloproteinase 12 inhibitors

By Singh Udghosh   Gangwal Rahul P.   Prajapati Rameshwar   Dhoke Gaurao V.   Sangamwar Abhay T.  

Molecular Simulation, Vol. 39, Iss. 5, 2013-04 ,pp. : 385-396

Taylor & Francis Ltd

Access to resources Recommend Favorite

Expression and Purification of Human Stromelysin 1 and 3 from Baculovirus-Infected Insect Cells

By del Mar Barbacid M.   Fernandez-Resa P.   Buesa J.M.   Marquez G.   Aracil M.   Quesadaand A.R.   Mira E.  

Protein Expression and Purification, Vol. 13, Iss. 2, 1998-07 ,pp. : 243-250

Academic Press

Access to resources Recommend Favorite

Crystal Structure of the Stromelysin-3 (MMP-11) Catalytic Domain Complexed With a Phosphinic Inhibitor Mimicking the Transition-state

By Gall A-L.   Ruff M.   Kannan R.   Cuniasse P.   Yiotakis A.   Dive V.   Rio M-C.   Basset P.   Moras D.  

Journal of Molecular Biology, Vol. 307, Iss. 2, 2001-03 ,pp. : 577-586

Academic Press

Access to resources Recommend Favorite

Apolactoferrin inhibits the catalytic domain of matrix metalloproteinase-2 by zinc chelation

By Newsome Anthony L.   Johnson Jon Paul   Seipelt Rebecca L.   Thompson Michael W.  

Biochemistry and Cell Biology, Vol. 85, Iss. 5, 2007-10 ,pp. : 563-572

NRC Research Press

Access to resources Recommend Favorite

Lack of matrix metalloproteinase (MMP)-1 and -3 expression in Ewing sarcoma may be due to loss of accessibility of the MMP regulatory element to the specific fusion protein in vivo

By Yabe H.   Fukuma M.   Urano F.   Yoshida K.   Kato S.   Toyama Y.   Hata J-i.   Umezawa A.  

Biochemical and Biophysical Research Communications, Vol. 293, Iss. 1, 2002-04 ,pp. : 61-71

Elsevier

Access to resources Recommend Favorite